ClinVar Miner

Submissions for variant NM_001142800.2(EYS):c.9405T>A (p.Tyr3135Ter)

gnomAD frequency: 0.00006  dbSNP: rs137853190
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000593252 SCV000709692 likely pathogenic not provided 2015-10-21 criteria provided, single submitter clinical testing The Y3156X likely pathogenic variant in the EYS gene has been reported previously in the homozygous state in two unrelated families with autosomal recessive retinitis pigmentosa (Collin et al., 2008). This variant is predicted to cause loss of normal protein function through protein truncation. Furthermore, the Y3156X variant was not observed in approximately 2,200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, we interpret Y3156X as a likely pathogenic variant
Counsyl RCV000000568 SCV000796512 likely pathogenic Retinitis pigmentosa 25 2017-12-19 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000000568 SCV000894389 likely pathogenic Retinitis pigmentosa 25 2018-10-31 criteria provided, single submitter clinical testing
Blueprint Genetics RCV001075385 SCV001241007 pathogenic Retinal dystrophy 2018-07-10 criteria provided, single submitter clinical testing
Invitae RCV000593252 SCV001587473 pathogenic not provided 2024-01-21 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr3135*) in the EYS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 10 amino acid(s) of the EYS protein. This variant is present in population databases (rs137853190, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with EYS-related conditions (PMID: 18976725, 29159838, 30337596, 31074760). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.9468T>A;p.Y3156X. ClinVar contains an entry for this variant (Variation ID: 538). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic.
CeGaT Center for Human Genetics Tuebingen RCV000593252 SCV001747467 pathogenic not provided 2021-06-01 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001723527 SCV001950254 pathogenic Retinitis pigmentosa 2021-04-01 criteria provided, single submitter curation The p.Tyr3135Ter variant in EYS was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3-P. Based on this evidence we have classified this variant as Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab.
Revvity Omics, Revvity RCV000000568 SCV002024538 likely pathogenic Retinitis pigmentosa 25 2019-12-11 criteria provided, single submitter clinical testing
Mendelics RCV000000568 SCV002519620 pathogenic Retinitis pigmentosa 25 2022-05-04 criteria provided, single submitter clinical testing
Baylor Genetics RCV000000568 SCV004192853 pathogenic Retinitis pigmentosa 25 2024-03-09 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003914789 SCV004736726 pathogenic EYS-related disorder 2024-03-01 criteria provided, single submitter clinical testing The EYS c.9405T>A variant is predicted to result in premature protein termination (p.Tyr3135*). This variant has been reported to be causative for autosomal recessive retinitis pigmentosa (Collin et al. 2008. PubMed ID: 18976725; Ezquerra-Inchausti et al. 2018. PubMed ID: 30337596; Messchaert et al. 2018. PubMed ID: 29159838). This variant is reported in 0.0050% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in EYS are expected to be pathogenic. This variant is interpreted as pathogenic.
OMIM RCV000000568 SCV000020717 pathogenic Retinitis pigmentosa 25 2008-11-01 no assertion criteria provided literature only
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000593252 SCV001959664 pathogenic not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000593252 SCV001975574 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.